Financial Data and Key Metrics Changes - The company reported better than expected results in Q1 2025, with revenue and profitability slightly above plan across all business segments [6][15] - Organic sales declined by 1% year-over-year, primarily due to difficult comparisons in semiconductor, agriculture, chemical, and energy businesses [15] - Adjusted EBITDA margin decreased by 50 basis points to 25.5% due to volume deleverage and margin dilution from the acquisition of Mak, partially offset by positive price cost and productivity [15][16] - Adjusted EPS for Q1 2025 was $1.75, exceeding the high end of the guidance by $0.10 [15] Business Line Data and Key Metrics Changes - In Health and Science Technology (HST), organic sales declined by 1%, while organic orders increased by 3% [18] - In Flow Measurement Technology (FMT), organic sales declined by 4% and organic orders declined by 3% [19] - Fire and Safety Division (FSD) saw organic sales increase by 5% and organic orders up by 2% [20] Market Data and Key Metrics Changes - The company experienced resilient demand overall, with organic orders up by 1% and backlog increasing by approximately $60 million [15] - The semiconductor business faced headwinds, particularly in wafer fabrication, while the MRO facing businesses provided a slight tailwind [9][18] Company Strategy and Development Direction - The company is focusing on five strong growth platforms and has identified integrative threats to support higher growth and expanded margins [25][26] - The strategy includes flat organizational structures with autonomous decision rights and a focus on quick iterative innovation [25][26] - The company is committed to returning capital to shareholders while exploring multiple avenues for capital deployment [26] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the fluid trade and geopolitical situation but noted that they have not observed any immediate signs of demand softening [21][22] - The company has proactively identified an additional $20 million in savings targets for 2025 to mitigate potential volume pressures [22] - Management expressed confidence in their ability to absorb the impact of tariffs through pricing actions and operational efficiencies [21][23] Other Important Information - The company reported a $40 million multiyear agreement for a custom wastewater filtration solution, with 25% of the order booked in Q1 [13] - The company has $490 million remaining under its current share repurchase authorization [16] Q&A Session Summary Question: Clarification on guidance and inputs - Management confirmed comfort with guidance and flexibility to manage inputs, including FX and cost savings [30][32] Question: Resilience of the portfolio amid macro pressures - Management highlighted strong growth platforms and productivity optimization as key to resilience [38][39] Question: Tariff impacts and pricing - Management indicated that the majority of tariff impacts will be seen in Q3 and Q4, with proactive pricing actions in place [45][46] Question: Strategic growth platforms and branding - Management explained the rationale behind combining businesses into strategic growth platforms while maintaining individual brand equity [77][78] Question: Update on semiconductor recovery - Management acknowledged industry challenges but noted some growth tailwinds in MRO facing businesses [70][72]

(All comparisons are against the prior year period unless otherwise noted) NORTHBROOK, IL, May 1, 2025 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2025. "Our IDEX teams delivered better than expected revenue and profitability in the first quarter of 2025, with all segments exceeding our expectations. Most encouragingly, all of our segments built backlog, mostly accumulating within HST, fueled by an impressive large clean water project win f ...

Core Insights - IDEX Biometrics ASA has published its annual report and remuneration report for 2024, along with its annual financial statements in European Single Electronic Format (ESEF) [1] - The company has disclosed a strategic shift to focus on the access market while continuing to leverage its efforts in the payment market, leading to adjustments in the 2024 financial statements [1] Financial Reporting - The preliminary financial statements for 2024 were disclosed on 27 February 2025 [1] - Adjustments to the 2024 statements of profit and loss and financial position were made, which were reflected in the interim balance sheet published on 21 March 2025 [1] Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions across payments, access control, and digital identity [2] - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [2]

IDEX Corporation (IEX) shares rallied 7.3% in the last trading session to close at $173.80. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.4% loss over the past four weeks.IDEX’s rally is largely driven by optimism over its strong momentum in the intelligent water business. The Trump administration’s announcement of a temporary halt on reciprocal tariffs for most countries has also supported the stock’s u ...

Group 1: Company Performance - IDEX Corporation (IEX) is experiencing solid momentum in the Fluid & Metering Technologies segment, with organic revenues increasing by 3% year-over-year in Q4 2024. The company anticipates overall organic revenues to rise by 1-3% year-over-year in 2025 [1] - The Health & Science Technologies segment is facing challenges, with organic revenues declining by 7% year-over-year in 2024 and remaining flat in Q4 [7] - Rising selling, general, and administrative expenses are impacting IDEX's bottom line, increasing by 14% year-over-year in Q4 2024, with costs of sales also rising by 9.7% [8] Group 2: Acquisitions and Growth Strategy - IDEX is focused on expanding its business through acquisitions, having acquired Mott Corporation for $1 billion in September 2024, enhancing its capabilities in applied materials science technology [2] - In December 2023, IDEX completed the acquisition of STC Material Solutions for $206 million, further strengthening its expertise in material sciences [3] - Acquisitions positively impacted sales by 6% in Q4 2024, indicating a successful integration of new businesses [3] Group 3: Shareholder Returns - Management is committed to rewarding shareholders, having paid dividends totaling $205.3 million in 2024, which is a 7.7% increase year-over-year [4] - The quarterly dividend rate was increased by 7.8% in May 2024, reflecting the company's focus on returning value to shareholders [4]

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Oslo, Norway – 31 March 2025 - Reference is made to the stock exchange announcements from IDEX Biometrics ASA (the "Compan ...

IDEX Biometrics ASA will hold an extraordinary general meeting (“EGM”) on Friday 11 April 2025 at 12.00 CET as an online meeting.  Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 March 2025 regarding the loan financing of NOK 30 million secured, proposed debt conversion, and amendment of Convertible Bond. The EGM-notice and the interim statement of financial position are attached. Shareholders may attend online by PC, smartphone or tablet. There is no physical attendance o ...

Group 1: Company Performance and Segments - IDEX Corporation (IEX) is expected to benefit from the strength in the Fluid & Metering Technologies segment, with organic revenues increasing by 3% year-over-year in Q4 2024 and an anticipated overall organic revenue growth of 1-3% in 2025 [1] - The company acquired Mott Corporation for $1 billion in September 2024, enhancing its applied materials science technology capabilities and micro-precision technology offerings in key markets [2] - In December 2023, IEX acquired STC Material Solutions for $206 million, which expanded its expertise in material sciences, contributing positively to sales by 6% in Q4 2024 [3] Group 2: Shareholder Returns - IEX has been committed to rewarding shareholders, with dividend payments totaling $205.3 million in 2024, reflecting a 7.7% year-over-year increase, and a 7.8% hike in its quarterly dividend rate announced in May 2024 [4] Group 3: Financial Challenges - The company faced escalating operating expenses, with a 9.7% year-over-year increase in the cost of sales and a 14% rise in selling, general, and administrative expenses in Q4 2024, leading to a 90 basis points increase in these expenses as a percentage of sales to 22.9% [7] - Weakness in the Health & Science Technologies segment due to softness in life sciences, analytical instrumentation, automotive, and semiconductor capital equipment markets raises concerns [6]

Group 1 - IDEX Biometrics has received a production order valued at approximately USD 50,000 from Beautiful Card Corporation for a biometric payment card program in the Japanese market [1] - Beautiful Card Corporation is positioned as a leader in the biometric smart card sector, focusing on payment and access cards globally [2] - IDEX Biometrics specializes in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity, leveraging patented technologies [3] Group 2 - The announcement was made in compliance with the EU Market Abuse Regulation and the Norwegian Securities Trading Act [5]

Core Viewpoint - IDEX Biometrics ASA has announced the commencement of the exercise period for Warrants A, allowing holders to subscribe for new shares at a price of NOK 0.15, with the exercise period running from 28 February 2025 to 13 March 2025 [2][3]. Company Information - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [6]. - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [6]. - IDEX Biometrics partners with leading card manufacturers and technology companies to bring its solutions to market [6]. Warrant Details - Each Warrant A allows the holder to subscribe for one new share at a subscription price of NOK 0.15, with unexercised Warrants A lapsing without compensation [3]. - The exercise procedure requires the submission of a completed exercise form and payment of the aggregate subscription price for the new shares [4]. - Warrants B will have a separate exercise period from 31 March 2025 to 11 April 2025 [3].